The punching bag of new medications takes another hit:
Analysts were forecasting blockbuster annual sales of $2bn (£1.01bn, E1.49bn) for the insulin spray. It delivered just $4m in the second quarter of 2007 ““ the first time Pfizer disclosed sales of the product.
